Literature DB >> 3319300

Polyclonal activation of murine B cells by a membrane proteoglycan of Klebsiella pneumoniae.

I Millet1, S Lafont, A de Fraissinette, M Jeannin, J P Revillard, G Normier, L Dussourd d'Hinterland.   

Abstract

The lymphocyte activating properties of a membrane proteoglycan (MPG) extracted from a mutant non-encapsulated strain of Klebsiella pneumoniae (Kp) (biotype a I-145) were investigated. Kp MPG induced a strong proliferative response of BALB/c spleen cells and Peyer's patches cells. Thymidine incorporation was dose-related (from 1 to 100 micrograms Kp MPG/ml) and reached a maximum at day 3. It was not reduced by removal of most adherent cells, nor by depletion of Thy1-2 positive cells, but it was abrogated by removal of surface immunoglobulin bearing cells. Spleen cells from nude mice and those from C3H/Hej mice were strongly stimulated by Kp MPG. Conversely Kp MPG did not induce interleukin 2 production and did not trigger the proliferation of thymocytes but stimulated interleukin 1 production by adherent spleen cells. Finally, unfractionated or B-enriched spleen cells cultured with Kp MPG synthesized IgM and, to a lesser extent, IgG and IgA. It is concluded that Kp MPG is a T-independent polyclonal B cell activator and an inducer of interleukin 1 production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319300      PMCID: PMC1542221     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Ribosomal vaccines: preparation of subcellular fractions.

Authors:  L Dussourd d'Hinterland; G Normier; J Durand
Journal:  Arzneimittelforschung       Date:  1980

2.  Cell walls, peptidoglycans, and teichoic acids of gram-positive bacteria as polyclonal inducers and immunomodulators of proliferative and lymphokine responses of human B and T lymphocytes.

Authors:  L Räsänen; H Arvilommi
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

3.  Purification to apparent homogeneity of murine interleukin 1.

Authors:  S B Mizel; D Mizel
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

4.  An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation.

Authors:  D Robert; P Bienvenu; S Lafont; B Jouanneteau; G Normier; L Dussourd D'Hinterland; R Fontanges
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

Review 5.  B cell subsets and differential responses to mitogens.

Authors:  J P McKearn; J W Paslay; J Slack; C Baum; J M Davie
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs.

Authors:  H Takada; M Tsujimoto; S Kotani; S Kusumoto; M Inage; T Shiba; S Nagao; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine immune system. I. T-independent polyclonal B cell activation.

Authors:  C D Wood; G Möller
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.

Authors:  S I Williamson; M J Wannemuehler; E Jirillo; D G Pritchard; S M Michalek; J R McGhee
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure-activity relationship.

Authors:  R Barot-Ciorbaru; J Brochier; T Miyawaki; J L Preud'Homme; J F Petit; C Bona; N Taniguchi; J P Revillard
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Pharmacology of ribosomal immunotherapy.

Authors:  J Clot
Journal:  Drugs       Date:  1997       Impact factor: 9.546

2.  Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens.

Authors:  Y S Li; E Kouassi; J P Revillard
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

3.  Monocyte cytokine secretion induced by chemically-defined derivatives of Klebsiella pneumoniae.

Authors:  Z Hmama; G Lina; C Vincent; J Wijdenes; G Normier; H Binz; J P Revillard
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Polyclonal B cell activation in paracoccidioidomycosis. Polyclonal activation in paracoccidioidomycosis.

Authors:  D Chequer-Bou-Habib; C Daniel-Ribeiro; D M Banic; A C do Valle; B Galvao-Castro
Journal:  Mycopathologia       Date:  1989-11       Impact factor: 2.574

5.  Immunological and biochemical characterization of biglycan-like haemopoietic factor.

Authors:  A Kikuchi; N Iwakami; K Takahashi; J Suzuki; J Kondo; E Yamada; I Nonaka; I Kamo
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

6.  The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo.

Authors:  M Petrek; E Weigl; M Ordeltová
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.